Ethicon Endo-Surgery recalled three units of the ECHELON LINEAR Cutters Reload 80 mm Blue on September 11, 2025. The devices were shipped unsterilized, posing a high health risk. The recall affects surgical devices in the United Arab Emirates.
The devices were shipped unsterilized.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Ethicon Endo-Surgery Inc or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is the ECHELON LINEAR Cutters Reload 80 mm Blue, Product Number GLC80. The specific model numbers include UDI-DI: 10705036030881 and Lot Number: 904C12. The devices were distributed internationally, specifically to the United Arab Emirates.
The devices were shipped unsterilized, which presents a significant risk of infection during surgical procedures. Unsterilized medical devices can lead to severe complications and healthcare-associated infections.
No specific incidents or injuries have been reported related to this recall. However, the lack of sterilization raises serious concerns regarding potential infections.
Stop using the device immediately. Follow the recall instructions provided by the manufacturer. For further guidance, contact Ethicon Endo-Surgery Inc or consult your healthcare provider.
For more information, reach Ethicon Endo-Surgery Inc at their official website. You can also visit the FDA recall report at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-0147-2026.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.